ArticleTransplantation direct2025
Sex Differences in Excess Mortality Among Waitlisted Kidney, Heart, and Liver Transplant Candidates.
Article in Transplantation direct, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sex differences in excess mortality risk (ie, above expected in the age-, sex-, and race-matched general population) among candidates waitlisted for transplant may reflect sex bias in access to the waitlist, disparities in allocation policies, and/or sex differences in care for patients with organ failure. Methods: We used time-dependent relative survival models to determine the relative excess risk of mortality in females compared with males recorded in the Scientific Registry of Transplant Recipients who were waitlisted for kidney, heart, or liver transplant from 1988 to 2019, accounting for the modifying effects of candidate age and listing era. Results: Among 644 262 kidney and 106 353 heart candidates, excess mortality was higher in female than male kidney candidates <60 y, but lower in female kidney candidates ≥60 y and heart candidates ≥12 y; patterns did not differ by era. Among 259 230 liver candidates, patterns differed by era of waitlisting. Excess mortality was lower for female than male liver candidates 0-12 and 25-44 y, and higher for females than males 13-24 y, without differences by era. Excess mortality was lower for female than male liver candidates 45-59 y waitlisted 1988-2011, but not different by sex for those waitlisted 2012-2019. Among liver candidates ≥60 y, excess mortality did not differ by sex for those waitlisted 1988-2011 but was higher for females than males waitlisted 2012-2019. Conclusions: The patterns of sex differences in excess mortality observed among waitlisted transplant candidates likely reflect the selection of healthier, lower-risk females than males for waitlisting and higher mortality risks for females with organ failure.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.